Particulars (Rupees in Crores.) | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 |
---|---|---|---|---|---|
Gross Sales | 14,761.23 | 11,939.68 | 12,328.29 | 11,167.72 | 11,351.8 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 14,761.23 | 11,939.68 | 12,328.29 | 11,167.72 | 11,351.8 |
Other Operating Income | 288.8 | 271.9 | 194.16 | 212.5 | 177.22 |
Other Income | 92.6 | 36.09 | 127.05 | 90.19 | 411.4 |
Total Income | 15,142.63 | 12,247.67 | 12,649.5 | 11,470.41 | 11,940.42 |
Total Expenditure | 12,238.04 | 10,991.23 | 12,503.89 | 9,531.85 | 10,537.89 |
PBIDT | 2,904.59 | 1,256.44 | 145.61 | 1,938.56 | 1,402.53 |
Interest | 240.32 | 181.75 | 101.3 | 108.8 | 255.6 |
PBDT | 2,664.27 | 1,074.69 | 44.31 | 1,829.76 | 1,146.93 |
Depreciation | 739.71 | 616.7 | 1,331.52 | 671.69 | 755.96 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 527.81 | 216.77 | 74.94 | 417.82 | 590.46 |
Deferred Tax | -170.6 | 35.92 | -364.52 | -23.31 | 461.58 |
Reported Profit After Tax | 1,567.35 | 205.3 | -997.63 | 763.56 | -661.07 |
Minority Interest After NP | 12.3 | 11.18 | 12.43 | 7.39 | -2.05 |
Net Profit after Minority Interest | 1,555.05 | 194.12 | -1,010.06 | 756.17 | -659.02 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 2,532.88 |
Adjusted Profit After Extra-ordinary item | 1,555.05 | 194.12 | -1,010.06 | 756.17 | -3,191.9 |
EPS (Unit Curr.) | 34.17 | 4.27 | -22.25 | 16.69 | -14.61 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 91.07 | 90.96 | 90.84 | 90.7 | 90.58 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 19.67 | 10.52 | 1.18 | 17.35 | 12.35 |
PBDTM(%) | 18.04 | 9 | 0.35 | 16.38 | 10.1 |
PATM(%) | 10.61 | 1.71 | -8.09 | 6.83 | -5.82 |
Lupin ranks as the third-largest pharmaceutical player in the U.S. by prescriptions and seventh in the Indian Pharmaceutical Market (IPM).
Lupin Limited reports a 77% increase in Q1 net profit to ₹801.3 crores, with total sales up 16.3%.
Here are some of the stocks that may see significant price movement today: Tata Power, Chambal Fertilisers, Cummins India, etc.
Here are some of the stocks that may see significant price movement today: Adani Energy Solutions, Bharti Airtel, Bharti Hexacom, etc.
According to the terms of the agreement, Lupin may receive up to $84 million in total payment based on future dependent milestones.
Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.
The inspection finished with no observations, and the facility was classified as "No Action Indicated" (NAI).
Here are some of the stocks that may see significant price movement today: HCL Technologies, Lupin, Piramal Pharma, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice